Related references
Note: Only part of the references are listed.Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma
Matias E. Valsecchi et al.
CANCER (2012)
Insulin-Like Growth Factor-I Receptor Blockade Reduces Tumor Angiogenesis and Enhances the Effects of Bevacizumab for a Human Gastric Cancer Cell Line, MKN45
Hua Li et al.
CANCER (2011)
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
Mitsuru Sasako et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Effect of type 1 insulin-like growth factor receptor targeted therapy on chemotherapy in human cancer and the mechanisms involved
Alyse Hopkins et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Gastrointestinal Stromal Tumor: An Ultrastructural Investigation on Regional Differences with Considerations on Their Histogenesis
Kyung-Whan Min
ULTRASTRUCTURAL PATHOLOGY (2010)
High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients
V. Ludovini et al.
ANNALS OF ONCOLOGY (2009)
Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition
Nikolaos A. Dallas et al.
CANCER RESEARCH (2009)
Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin
Yasushi Adachi et al.
CARCINOGENESIS (2009)
Expression Levels of Insulin-Like Growth Factor-1 and Multidrug Resistance-Associated Protein-1 Indicate Poor Prognosis in Patients with Gastric Cancer
Jie Ge et al.
DIGESTION (2009)
IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivin
Caroline Hilmi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
Shinichi Sakuramoto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Evaluation of malignant and benign gastric biopsy specimens by mRNA expression profile and multivariate statistical methods
Orsolya Galamb et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2007)
Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma
Arisa Imsumran et al.
CARCINOGENESIS (2007)
Methods for categorizing a prognostic variable in a multivariable setting
M Mazumdar et al.
STATISTICS IN MEDICINE (2003)
Gastric cancer: the role of insulin-like growth factor 2 (IGF 2) and its receptors (IGF I R and M6-P/IGF 2R)
K Pavelic et al.
JOURNAL OF PATHOLOGY (2003)
Overexpression of the insulin-like growth factor I receptor in human colon carcinomas
MM Weber et al.
CANCER (2002)
Insulin-like growth factors and cancer
G Fürstenberger et al.
LANCET ONCOLOGY (2002)
Inhibition of the type 1 insulin-like growth factor receptor expression and signaling: Novel strategies for antimetastatic therapy
P Brodt et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Share Paper
